(Q87419544)
Statements
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results (English)
R Coleman
R de Boer
H Eidtmann
A Llombart
N Davidson
P Neven
H P Sleeboom
J Forbes
C Barrios
I Campbell
O Paija
N Martin
A Modi